People who use cannabis are less likely to be obese than those that do not. This intriguing finding was just revealed in the American Journal of Epidemiology. Two large epidemiological studies found far lower rates of obesity and BMI in cannabis consumers versus abstainers.
Such finding are particularly important when obesity threatens human well-being across the planet. Especially in the USA, but also now world wide, this plague of pounds drives degenerative diseases and health care costs. Obesity is a chronic low grade inflammation. Fat cells displace organs and produce cellular toxins. Obesity kills at least one out of eight Americans.
Should cannabis use worsen this obesity problem, it might be an important contraindication for medical cannabis use. Cannabis consumption is, after all, commonly associated with “the munchies.” Medically it is useful in helping those with wasting syndrome gain weight. The cardiometabolic aspects of enhancing the endocannabinoid response be activating CB1 and CB2 receptors do not seem very beneficial. If anything, they seem negative from several cardiometabolic parameters, such as adiponectin levels.
Remember, it was the cannabinoid receptor antagonist, Rimonabant, that was just a few years ago thought to have a major future as an anti-obesity drug. This “anti-marijuana” was supposed to give you the “anti-munchies.” But human trials showed it also caused an “anti-high”, exhibited by anxiety, depression and suicidal thoughts. It was never approved by the FDA.
The new study, however, shows higher consumption of cannabis with reduced rates of obesity. The authors conclude, “that the prevalence of obesity is lower in cannabis users than in nonusers.” The study was controlled for cigarette smoking. The authors did not speculate by what mechanism cannabis consumers were more free from obesity than people not consuming cannabis.
Generally, the best method to freedom from obesity is to be physically active, walk at least 10,000 steps per day, and maintain a nutritious, calorie-lean diet.